Transplantation outcome by diagnosis
. | AML; n = 13 . | MDS; n = 7 . | CML; n = 9 . |
|---|---|---|---|
| Median age, y (range) | 60 (55-69) | 61 (55-64) | 58 (55-62) |
| Median follow-up of patients alive, d (range) | 817 (104-1642) | 910 (872-1540) | 495 (336-1016) |
| Overall survival at 1 year, %* | 36.9 ± 13.8 | 42.9 ± 18.7 | 55.5 ± 16.5 |
| Relapse-free survival at 1 year, %* | 36.9 ± 13.8 | 42.9 ± 18.7 | 44.4 ± 16.5 |
| Transplant-related mortality at 1 year, %* | 55.2 ± 13.8 | 46.4 ± 20.1 | 44.4 ± 16.5 |
. | AML; n = 13 . | MDS; n = 7 . | CML; n = 9 . |
|---|---|---|---|
| Median age, y (range) | 60 (55-69) | 61 (55-64) | 58 (55-62) |
| Median follow-up of patients alive, d (range) | 817 (104-1642) | 910 (872-1540) | 495 (336-1016) |
| Overall survival at 1 year, %* | 36.9 ± 13.8 | 42.9 ± 18.7 | 55.5 ± 16.5 |
| Relapse-free survival at 1 year, %* | 36.9 ± 13.8 | 42.9 ± 18.7 | 44.4 ± 16.5 |
| Transplant-related mortality at 1 year, %* | 55.2 ± 13.8 | 46.4 ± 20.1 | 44.4 ± 16.5 |
Kaplan-Meier estimate and 95% Cl.